Researchers at MD Anderson Cancer Center demonstrated that stereotactic ablative radiotherapy was as effective as surgery at providing long-term benefits to patients with operable early-stage non-small cell lung cancer and generated minimal side effects.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe